Search…

    Saved articles

    You have not yet added any article to your bookmarks.

    Browse articles

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policies, and Terms of Service.

    Medicare and Medicaid won’t pay for popular obesity drugs like Wegovy and Zepbound, rejecting, at least for now, a Biden administration proposal that would have expanded coverage for weight loss

    3 weeks ago

    6

    0

    The Biden administration had proposed late last year coverage of the popular medicines for obesity.
    Click here to Read more
    Prev Article
    The Texas measles outbreak has led to the death of a second child
    Next Article
    In an interview with The Wall Street Journal, Dr. Peter Marks, the FDA’s outgoing vaccine chief, says RFK Jr.’s team wants to show vaccines aren’t safe while weakening rules on unproven treatments

    Related Health Updates:

    Comments (0)

      Leave a Comment